Impact of genetic polymorphisms of 17‐hydroxylase cytochrome P‐450 (CYP17) and steroid 5α‐reductase type II (SRD5A2) genes on prostate‐cancer risk among the Japanese population
暂无分享,去创建一个
T. Katoh | Y. Kubota | M. Murata | T. Shiraishi | R. Yatani | M. Yamanaka | Yasushi Yamada | M. Watanabe | M. Yamanaka | Y. Kubota | J. Kawamura | H. Ito | Y. Yamada | J. Kawamura